JP2008515980A5 - - Google Patents

Download PDF

Info

Publication number
JP2008515980A5
JP2008515980A5 JP2007536818A JP2007536818A JP2008515980A5 JP 2008515980 A5 JP2008515980 A5 JP 2008515980A5 JP 2007536818 A JP2007536818 A JP 2007536818A JP 2007536818 A JP2007536818 A JP 2007536818A JP 2008515980 A5 JP2008515980 A5 JP 2008515980A5
Authority
JP
Japan
Prior art keywords
osamu
prostaglandins
prevention
ester
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007536818A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008515980A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/036558 external-priority patent/WO2006044405A1/en
Publication of JP2008515980A publication Critical patent/JP2008515980A/ja
Publication of JP2008515980A5 publication Critical patent/JP2008515980A5/ja
Pending legal-status Critical Current

Links

JP2007536818A 2004-10-12 2005-10-11 閉塞性動脈疾患のためのアリールスルホンアミドぺリ置換二環式化合物 Pending JP2008515980A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61820204P 2004-10-12 2004-10-12
PCT/US2005/036558 WO2006044405A1 (en) 2004-10-12 2005-10-11 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease

Publications (2)

Publication Number Publication Date
JP2008515980A JP2008515980A (ja) 2008-05-15
JP2008515980A5 true JP2008515980A5 (https=) 2008-11-27

Family

ID=35677621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007536818A Pending JP2008515980A (ja) 2004-10-12 2005-10-11 閉塞性動脈疾患のためのアリールスルホンアミドぺリ置換二環式化合物

Country Status (16)

Country Link
US (2) US20060142348A1 (https=)
EP (1) EP1812426B1 (https=)
JP (1) JP2008515980A (https=)
KR (1) KR20070085340A (https=)
CN (1) CN101076529A (https=)
AT (1) ATE512144T1 (https=)
AU (1) AU2005295902A1 (https=)
BR (1) BRPI0517417A (https=)
CA (1) CA2583710A1 (https=)
IL (1) IL182489A0 (https=)
MX (1) MX2007004526A (https=)
NO (1) NO20072269L (https=)
NZ (1) NZ554493A (https=)
RU (1) RU2407736C2 (https=)
SG (1) SG156637A1 (https=)
WO (1) WO2006044405A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT200500185A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
ES2524922T3 (es) 2005-05-10 2014-12-15 Intermune, Inc. Derivados de piridona para modular el sistema de proteína cinasa activada por estrés
US20090163586A1 (en) 2007-12-20 2009-06-25 Astrazeneca Ab Bis-(Sulfonylamino) Derivatives in Therapy 205
CA2726588C (en) 2008-06-03 2019-04-16 Karl Kossen Compounds and methods for treating inflammatory and fibrotic disorders
FR2938538B1 (fr) * 2008-11-17 2011-08-05 Univ Nice Sophia Antipolis Procede de preparation d'acides et d'esters boroniques en presence de magnesium metallique
CA2756870A1 (en) 2009-03-31 2010-10-07 Arqule, Inc. Substituted indolo-pyridinone compounds
JP5841361B2 (ja) * 2011-06-29 2016-01-13 壽製薬株式会社 三環性化合物及びそれを含有する医薬組成物
JO3407B1 (ar) 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
US9546162B2 (en) * 2013-09-27 2017-01-17 Allergan, Inc. Compounds and methods for skin repair
MX382781B (es) 2014-04-02 2025-03-13 Intermune Inc Piridinonas anti-fibroticas.
GB201810092D0 (en) 2018-06-20 2018-08-08 Ctxt Pty Ltd Compounds
GB201810581D0 (en) 2018-06-28 2018-08-15 Ctxt Pty Ltd Compounds
KR102823056B1 (ko) 2019-06-18 2025-06-23 화이자 인코포레이티드 벤즈이속사졸 설폰아마이드 유도체

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2150113T3 (es) * 1995-04-03 2000-11-16 Novartis Ag Derivados de pirazol y procedimientos para la preparacion de los mismos.
ZA984040B (en) * 1997-05-15 1998-11-20 Ono Pharmaceutical Co Benzenesulfonamide compounds
TR200201431T2 (tr) * 1999-11-30 2002-09-23 Pfizer Products Inc. İmünosupresanlar olarak faydalı 2,4-diaminopirimidin bileşikleri
MXPA04001253A (es) * 2001-08-09 2004-06-03 Ono Pharmaceutical Co Derivados de acidos carboxilicos y agente farmaceutico que comprende los mismos como ingrediente activo.
JPWO2004078719A1 (ja) * 2003-03-06 2006-06-08 小野薬品工業株式会社 インドール誘導体化合物およびその化合物を有効成分とする薬剤
CA2528626A1 (en) * 2003-07-09 2005-01-20 Biolipox Ab Indoles useful in the treatment of inflammation
CA2550361C (en) * 2003-12-19 2014-04-29 Prabha Ibrahim Compounds and methods for development of ret modulators

Similar Documents

Publication Publication Date Title
JP2007501251A5 (https=)
JP2003520232A5 (https=)
JP2008515980A5 (https=)
JP2003503454A5 (https=)
JP2008513467A5 (https=)
JP2012502037A5 (https=)
JP2006517944A5 (https=)
JP2009545527A5 (https=)
JP2010528011A5 (https=)
JP2009538898A5 (https=)
ME02688B (me) Hinazolinoni kao inhibitori humane fosfatidilinozitol 3 - kinaze delta
CL2007001993A1 (es) Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat
HRP20220902T3 (hr) Pripravci i njihova upotreba u liječenju multiple skleroze
JP2006503588A5 (https=)
JP2009537554A5 (https=)
BRPI0618211B8 (pt) composição farmacêutica contendo pregabalina para dosagem uma vez ao dia e uso do referido composto
JP2010507682A5 (https=)
JP2010535814A5 (https=)
JP2007520565A5 (https=)
JP2005513006A5 (https=)
JP2011527299A5 (https=)
JP2008513510A5 (https=)
JP2007523135A5 (https=)
ATE505203T1 (de) Pharmazeutische kombination aus aliskiren und valsartan
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend